| CLASS | DRUG/TOX | LP7790-1 |
| COMPONENT | Ravulizumab | LP422971-4 |
| PROPERTY | MCnc | LP6827-2 |
| TIME_ASPCT | Pt | LP6960-1 |
| SYSTEM | Ser | LP7567-3 |
| SCALE_TYP | Qn | LP7753-9 |
| parent | Ravulizumab | Serum | Drug toxicology | LP427423-1 |
| CLASSTYPE | Laboratory class | |
| ORDER_OBS | Both | |
| EXAMPLE_UNITS | mcg/mL | |
| EXAMPLE_UCUM_UNITS | ug/mL | |
| UNITSREQUIRED | N | |
| STATUS | ACTIVE |
| LONG_COMMON_NAME | en-US | Ravulizumab [Mass/volume] in Serum |
| LONG_COMMON_NAME | en-US | Ravulizumab [Mass/volume] in Serum |
| SHORTNAME | en-US | Ravulizumab Ser-mCnc |
| ConsumerName | en-US | Ravulizumab, Blood |
| LONG_COMMON_NAME | fr-FR | Ravulizumab [Masse/Volume] Sérum ; Numérique |
| LONG_COMMON_NAME | nl-NL | Ravulizumab [massa/volume] in serum |
| LONG_COMMON_NAME | es-MX | Ravulizumab:Suero :Punto temporal:MCnc:Cuantitativo: |
LOINC Version: 2.81
FHIR